Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

GLP-1RA medications may increase the risk of hair loss, especially in non-diabetic people.

Delta opioid receptors help regulate touch sensation by reducing neurotransmitter release in the spinal cord.

GLP-1 and GLP-1/GIP agonists may increase the risk of hair loss.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

RXR agonists may promote hair growth in humans.

Enhanced stem cells from the placenta can reduce fat cell formation in eye disease.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

GLP-1 receptor agonists may help or harm hair health, needing more research.

Blocking certain brain processes reduces mating behavior in female rats.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

More research is needed to understand if GLP-1 agonists affect hair health.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

GLP-1 medications can cause skin and muscle issues, but treatments like ultrasound and PRP can help.

Enhanced stem cells can reduce fat buildup in eye tissue for Graves' disease.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Incretin-based drugs for obesity often cause gastrointestinal issues, with tirzepatide having the most reports.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.